Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology

What problem does this paper attempt to address?

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Tao Wang,Tianye Li,Baiqing Li,Jiahui Zhao,Zhi Li,Mingyi Sun,Yan Li,Yanjiao Zhao,Shidi Zhao,Weiguang He,Xiao Guo,Rongjing Ge,Lian Wang,Dushan Ding,Saisai Liu,Simin Min,Xiaonan Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1134847

IF: 7.3

2023-01-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

immunology
Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Jinguo Zhang,Benjie Shan,Lin Lin,Jie Dong,Qingqing Sun,Qiong Zhou,Jian Chen,Xinghua Han

DOI: https://doi.org/10.3389/fcell.2021.812770

IF: 5.5

2021-12-09

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.711859.].

cell biology,developmental biology
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Jia Yao,Shengwei Li,Xiaosheng Wang

DOI: https://doi.org/10.3389/fcell.2022.948644

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.781848.].
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Min Zhou,Shasha Hong,Bingshu Li,Cheng Liu,Ming Hu,Jie Min,Jianming Tang,Li Hong

DOI: https://doi.org/10.3389/fgene.2022.951409

IF: 3.7

2022-08-15

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.675197.].

genetics & heredity
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Peijie Chen,Yuting Gao,Si Ouyang,Li Wei,Min Zhou,Hua You,Yao Wang

DOI: https://doi.org/10.3389/fphar.2021.723153

IF: 5.6

2021-08-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.585255.].

pharmacology & pharmacy
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Yangyang Guo,Kenan Cen,Qiaoqiao Chen,Ying Dai,Yifeng Mai,Kai Hong

DOI: https://doi.org/10.3389/fimmu.2023.1229541

IF: 7.3

2023-06-05

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1128390.].

immunology
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Wei Zhang,Weiwei Wang,Junlu Wu,Jiale Tian,Wenhui Yan,Yi Yuan,Yiwen Yao,Anquan Shang,Wenqiang Quan

DOI: https://doi.org/10.3389/fonc.2022.1118042

2022-12-15

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.942964.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Xueting Wan,Mengyao Song,Aiyun Wang,Yang Zhao,Zhonghong Wei,Yin Lu

DOI: https://doi.org/10.3389/fimmu.2022.887775

IF: 7.3

2022-04-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.747914.].

immunology

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy